Back to Markets
KNKiniksa Pharmaceuticals International, PLC

Kiniksa Pharmaceuticals International, PLC

KNSANASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$48.38

-2.460000 (-4.84%)

As of 05/29/26 EDT · USD

Compare
Low: $26.27Current: $48.38High: $59.87

Key Statistics

Open

$50.72

Day High

$50.80

Day Low

$48.06

Prev. Close

$50.84

VolumeShares traded today.

670.17K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$3.72B

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

53.35

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$59.87

52W LowLowest price over the past 52 weeks.

$26.27

50D MAAverage closing price over the last 50 trading days.

$50.15

200D MAAverage closing price over the last 200 trading days.

$42.80

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

-9.8%

1M

-8.7%

6M

+13.3%

YTD

+15.2%

1Y

+76.8%

About

Cambridge Antibody Technology Group Plc, was a biotechnology company headquartered in Cambridge, England. Its core focus was on antibody therapeutics, primarily using Phage Display and Ribosome Display technology.

www.kiniksa.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade KNSA

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.